Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Search in:

Advanced search

Patient Preference and Adherence Volume 10, 2016 - Issue

Submit an article Journal homepage

Open access

Views

CrossRef citations to date

Altmetric

Original Research

Three-year outcome analysis of alpha 1-blocker naftopidil for patients with benign prostatic hyperplasia in a prospective multicenter study in Japan

Naoya Masumori1 Department of Urology, Sapporo Medical University School of Medicine, SapporoCorrespondence[email protected]

Taiji Tsukamoto1 Department of Urology, Sapporo Medical University School of Medicine, Sapporo

Akihiko Shibuya2 Kaguraoka Urological Clinic, Asahikawa

Noriomi Miyao3 Division of Urology, Muroran City General Hospital, Muroran

Yasuharu Kunishima4 Hokkaido Social Work Association Obihiro Hospital, Obihiro

Akihiko Iwasawa5 Iwasawa Clinic, Sapporo, Japan

Pages 1309-1316 | Published online: 22 Jul 2016

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (3)

Osama A. Zitoun, Abdulrahman MN. Farhat, Mohamed A. Mohamed, Mohammad R. Hamad, Beatrice Aramini & Khawaja Husnain Haider. (2020) Management of benign prostate hyperplasia (BPH) by combinatorial approach using alpha-1-adrenergic antagonists and 5-alpha-reductase inhibitors. European Journal of Pharmacology 883, pages 173301.
Crossref

Koji Ichihara, Naoya Masumori, Akihiko Iwasawa, Keisuke Taguchi, Yasuhiro Yamaguchi, Masahiro Nishimura, Hiroto Sasamura, Nobukazu Suzuki, Kazunori Haga, Noriomi Miyao & Takaoki Hirose. (2018) Silodosin as second-line α-blocker monotherapy in patients with benign prostatic hyperplasia: A prospective observational study. International Journal of Urology 25:10, pages 849-854.
Crossref

Yoshinori Tanaka, Yasushi Tanuma & Naoya Masumori. (2017) The Persistence of Silodosin Monotherapy and the Reasons for Withdrawal from Treatment of Previously Untreated Japanese Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia. Advances in Urology 2017, pages 1-6.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references